SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AFFYMETRIX (AFFX) -- Ignore unavailable to you. Want to Upgrade?


To: Barbara Bullard who wrote (735)6/28/1998 11:07:00 PM
From: Andy Patton  Respond to of 1728
 
It's always guesswork about when to buy a company such as AFFX, since it's really impossible to value.

But here goes: I'd buy now. (I'd buy more myself but before I get into a company like AFFX, I set myself a limit of the maximum amount of money I'm willing to commit to it, i.e. that I'd run the risk of losing--and I'm already at that limit, so I can't buy more, according to my own rules.) For what it's worth, I bought at 31 3/8 average price, and held through the latest drop. Its 52 week high was 40-something, so it has dropped substantially, yet to my eye, the company is further advanced in establishing its technology as an industry standard than it was when the stock was much higher.

From what you've written, it sounds as though you're considering buying it for "the story"--frowned on in some circles, but still legit (to me). Whatever your reason for buying--my advice (if you buy) is to stick with it unless and until that reason is no longer valid. AFFX--even it pays off--will be up and down dramatically.

My 2 bits:
Research some more. Read this list, Inctye's, Nanogen (AFFX competitors.) Make a list of AFFX partners and collaborators--see what you think of that "industry map." Definitely get the company annual report. Check dejanews. and if you do buy: be very clear about why you're buying and stick to that reasoning, re-examining it periodically.

Hope this is helpful.

-Andy



To: Barbara Bullard who wrote (735)6/29/1998 2:56:00 AM
From: JF Quinnelly  Read Replies (1) | Respond to of 1728
 
If you wait for a general market correction you might get a better price. But this stock likes to move on news, so it's hard to guess when it may run. The growth rate of sales appears to be a proxy for earnings, since there aren't any. And you might want to spread your investment to include some of AFFX's rivals as well: Incyte (INCY) is another promising company in the same field. There is also Nanogen and Hyseq.